Table 1.
Phthalate diesters and corresponding metabolites.
Table 2.
Demographic characteristics of participating infants.
Table 3.
Distribution of specific gravity-adjusted phthalate concentrations measured in the cohort (ng/mL).
Table 4.
NNNS performance.
Table 5.
Adjusted multivariable linear regression of the association between ∑DEHP and NNNS summary scalesa.
Table 6.
Association of outcome-specific weighted indices of phthalate biomarkers with summary scale performance on the NICU Network Neurobehavioral Scalea.
Fig 1.
∑DEHP metabolites by medical equipment exposure group.
Molar ∑DEHP metabolites represented in ng/mL using the molecular weight of MEHP for conversion. Twenty-fifth percentile, median, and 75th percentile values in ng/mL are indicated for each medical equipment exposure group. Groups 1–3 are as defined in the Methods section, with group 1 representing the lowest exposure to medical equipment and group 3 representing the highest acuity, highest intensity equipment exposure.